The Future of Personalized Medicine: Leveraging Customization for Faster Insights

Q4 Biochemistry, Genetics and Molecular Biology Genetic Engineering & Biotechnology News Pub Date : 2023-11-01 DOI:10.1089/gen.43.11.16

引用次数: 0

Abstract

Genetic Engineering & Biotechnology NewsVol. 43, No. 11 Sponsored ContentThe Future of Personalized Medicine: Leveraging Customization for Faster InsightsPublished Online:9 Nov 2023https://doi.org/10.1089/gen.43.11.16AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 11Nov 2023 Information© 2023 by GEN PublishingTo cite this article:The Future of Personalized Medicine: Leveraging Customization for Faster Insights.Genetic Engineering & Biotechnology News.Nov 2023.45-45.http://doi.org/10.1089/gen.43.11.16Published in Volume: 43 Issue 11: November 9, 2023PDF download

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

个性化医疗的未来:利用定制获得更快的见解

基因工程与生物技术新闻卷。43、第11期赞助内容个性化医疗的未来:利用定制更快的洞察力出版在线:9 Nov 2023https://doi.org/10.1089/gen.43.11.16AboutSectionsView文章查看全文pdf /EPUB权限和citationspermissions下载CitationsTrack citations添加到收藏回到出版物共享分享上facebook推特链接InRedditEmail查看文章figuresreferencesrelateddetails卷43期11Nov 2023信息©2023 by GEN publishing引用这篇文章:个性化医疗的未来:利用定制来获得更快的洞察力。基因工程与生物技术新闻。Nov 2023.45-45.http://doi.org/10.1089/gen.43.11.16Published in Volume: 43 Issue 11:十一月9,2023PDF下载

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Genetic Engineering & Biotechnology News 工程技术-生物工程与应用微生物

CiteScore

0.20

自引率

0.00%

发文量

210

审稿时长

3-6 weeks

期刊介绍： Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry. Through its cornerstone Magazine, high-frequency newsletters, and dynamic suite of multimedia resources, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their organization’s success. GEN’s breadth of editorial coverage is unrivaled in the industry, providing exclusive coverage of the entire bioproduct lifecycle across five key pillars: Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing.

期刊最新文献

Organoids Deliver True-to-Life Performances CRISPR-Edited Silkworms Spin Spider Silk Tougher Than Kevlar Multiomics in Pancreatic Cancer: A Conversation with Dr. William Hwang The Future of Personalized Medicine: Leveraging Customization for Faster Insights NGS Sample Prep: Enduring Basics and Evolving Enzyme Kits